The present invention is directed to 1.alpha.,25-dihydroxyvitamin D3 mimicswhich modulate the vitamin D receptor (VDR). The invention is further directedto pharmaceutical compositions and methods for the treatment, prevention oramelioration of one or more symptoms of disease or disorder related to theactivity of the vitamin D receptor using an effective amount of a compound offormula (I).